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Polyclonal Mucosa-Associated Invariant T Cells Have Unique Innate
Functions in Bacterial Infection
Wei-Jen Chua,a Steven M. Truscott,b Christopher S. Eickhoff,b Azra Blazevic,b Daniel F. Hoft,b and Ted H. Hansena
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA,a and Division of Infectious Diseases, Allergy and
Immunology, Department of Internal Medicine, Saint Louis University Medical Center, St. Louis, Missouri, USAb
Mucosa-associated invariant T (MAIT) cells are a unique population ofT cells inmammals that reside preferentially inmucosal
tissues and express an invariantVpairedwith limitedVT-cell receptor (TCR) chains. Furthermore,MAIT cell development is de-
pendent upon the expression of the evolutionarily conservedmajor histocompatibility complex (MHC) class IbmoleculeMR1.Using
in vitro assays, recent studies have shown thatmouse and humanMAIT cells are activated by antigen-presenting cells (APCs) infected
with diversemicrobes, including numerous bacterial strains and yeasts, but not viral pathogens.However, whetherMAIT cells play an
important, and perhaps unique, role in controlling microbial infection has remained unclear. To probeMAIT cell function, we
show here that purified polyclonal MAIT cells potently inhibit intracellular bacterial growth ofMycobacterium bovis BCG in
macrophages (M) in coculture assays, and this inhibitory activity was dependent uponMAIT cell selection byMR1, secretion
of gamma interferon (IFN-), and an innate interleukin 12 (IL-12) signal from infectedM. Surprisingly, however, the cognate
recognition of MR1 byMAIT cells on the infectedMwas found to play only a minor role inMAIT cell effector function.We
also report that MAIT cell-deficient mice had higher bacterial loads at early times after infection compared to wild-type (WT)
mice, demonstrating that MAIT cells play a unique role among innate lymphocytes in protective immunity against bacterial
infection.
Innate and adaptive components of the cellular immune systemfunction sequentially to provide protection against microbial
infection. Unlike conventional CD4 and CD8 T cells, which must
undergo clonal expansion in response to infection, NK cells ex-
pressing germ line-encoded receptors respond rapidly to kill in-
fected cells or release cytokines and provide the initial defense
during infection. To kinetically bridge the innate and adaptive
responses, innate T cells, such as invariant natural killer T (iNKT)
cells and M3-restricted T cells, respond more quickly than con-
ventional T cells to infection. Innate T cells are less dependent
upon clonal expansion than conventional CD4 and CD8 T cells,
because they appear to detectmolecular patterns or danger signals
rather than specific peptides bound to polymorphic major histo-
compatibility complex (MHC) molecules. For example, iNKT
cells use an invariant T-cell receptor alpha (TCR) chain (V24-
J18 in humans and the homologous V14-J18 in mice) com-
bined with a limited set of TCR chains to detect the nonclassical
MHC class I (class Ib)molecule CD1d, which binds an assortment
of self and microbial lipid antigens. However, iNKT cells display
little antigen discrimination, since the invariant TCR chain pri-
marily engages the CD1d-lipid complex while the TCR chain
makes limited contact (6). Additionally, iNKT cell activation can
occur by various pathways, some of which do not require the
iNKT detection of CD1d (8, 74). Therefore, with a limited TCR
repertoire, iNKT cells can rapidly secrete cytokines in response to
a wide range of infections by bacterial, viral, protozoan, or fungal
pathogens. The immunomodulatory role of iNKT cells is well es-
tablished, but the physiological role of iNKT cells in host immu-
nity remains incompletely understood (4, 69).Mucosa-associated
invariant T (MAIT) cells, a recently identified T-cell subset in
mammals, share striking similarities and interesting differences
with iNKT cells (73). MAIT cells have been implicated recently in
detection of diverse microbial infections (33, 50), raising impor-
tant questions of whether and how they might function in patho-
gen protection as an addition to the innate T-cell population.
Unlike iNKT cells, MAIT cells preferentially reside in mucosal
tissues, and their homotypic expansion is dependent upon com-
mensalmicrobes (72). In addition,MAIT cells aremore abundant
in humans than mice, whereas iNKT cells are more abundant in
mice than humans (73). Similar to iNKT cells, MAIT cells express
an invariant TCR that recognizes a novel nonpolymorphic class Ib
molecule. More specifically, MAIT cells express an invariant
TCR chain (V7.2-J 33 in humans and the homologous V19-
J33 in mice) that is preferentially associated with certain TCR
chains (V2, V13, and V22 in humans and V6 and V8 in
mice) (45, 71). Most mouse MAIT cells are CD4/CD8 double
negative (DN), but some are also singly positive for CD8 or CD4
coreceptors (45, 55, 72).HumanMAIT cells have been reported in
either the DN or CD8 subsets (33, 55, 71). The developmental
selection and peripheral activation of MAIT cells is restricted by
the nonpolymorphic class Ib molecule MHC-related protein 1
(MR1) (72). The selection of MAIT cells in the thymus requires
the expression of MR1 on hematopoietic cells, likely including
double-positive (DP) thymocytes, macrophages (M), and den-
dritic cells (DCs) (13, 55, 72). The Mr1 gene is highly conserved
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among mammals (64, 78, 79). The predicted amino acid se-
quences ofmouse andhumanMR1 are 89%/90% identical in their
1/2 domains. In contrast, mouse and human CD1 1/2 do-
mains are only 60%/62% identical (38). Interestingly, the se-
quence analysis of Mr1 gene orthologs has indicated their strong
purifying selection during evolution, suggesting their physiologi-
cal importance (41). In functional support of this conclusion,
mouse and humanMAIT cells, like iNKT cells, have the ability to
be activated in a cross-species manner (41).
The notion that MR1 presents antigen to MAIT cells is sup-
ported by extensive mutagenesis studies (39, 56) as well as by the
fact that allT cells characterized thus far detectMHCorMHC-
like molecules bound by antigen. What is known about the MR1
presentation pathway is that MAIT cell development and activa-
tion is independent of transporters associated with antigen pro-
cessing (TAP) (40, 71). Moreover, the activation of mouse MAIT
cell hybridomas byMR1-overexpressing cell lines was found to be
proteasome independent and enhanced by endocytic trafficking
(40). Thus, MR1 clearly does not use the same antigen presenta-
tion pathway as classical MHC class I (class Ia) molecules. More
interestingly, unlike class Ia or CD1 molecules, which are consti-
tutively expressed on the plasma membranes of antigen-present-
ing cells (APCs), MR1 proteins reside mostly in the endoplasmic
reticulum (ER), and only low levels have been detected at the
plasma membrane (13, 35, 40). However, surface expression of
mouse MR1 can be stabilized at the cell surface using selective
monoclonal antibodies (MAbs) (13), whereas human MR1 was
shown to be inducible on a human lung epithelial cell line after in
vitro infection withMycobacterium tuberculosis (33). Collectively,
these findings demonstrate that MR1 activation of MAIT cells
represents a novel and unique mechanism of  T-cell activation
that has been conserved throughout mammalian evolution, sug-
gesting physiologic importance in host immunity.
In support of their physiologic importance, two recent studies
showed that human and mouse MAIT cells can detect microbial
infection in an MR1-restricted manner (33, 50). In a human
study, Gold et al. cloned M. tuberculosis-reactive CD8 T cells
from infected and uninfected individuals and found in both pop-
ulations that a high frequency of the M. tuberculosis-reactive T
cells are human MR1-restricted MAIT cells (33). Furthermore,
theseM. tuberculosis-reactive humanMAIT cells are also activated
by APCs infected with other bacterial strains, including Esche-
richia coli, Salmonella enterica serovar Typhimurium, and Staph-
ylococcus aureus but not Listeria monocytogenes. A concomitant
study by Le Bourhis et al. showed that both mouse and human
MAIT cells display activationmarkers after in vitro coculture with
APCs infected with various strains of bacteria and yeasts but not
viral pathogens (50). This highly cross-reactive recognition of mi-
crobial-infected APCs byMAIT cells suggests that their activation
may be more similar to pattern recognition than ligand discrimi-
nation. However, the upregulation of activation markers on
MAIT cells was found not to be dependent upon known innate
receptors or adaptors, including Toll-like receptors (TLRs), Nod-
like receptors,MyD88, andTRIF (50). In contrast, innate receptor
pathways have been shown to be important in iNKT cell activation
both in vivo and in vitro (8, 9, 15, 59, 74, 75). Regarding the clinical
relevance of MAIT cells, the two studies mentioned above re-
ported that patients with ongoing M. tuberculosis infection have
fewer MAIT cells in the blood and higher levels in the lung than
healthy individuals (33, 50). This observation suggested that
MAIT cells could migrate from the periphery into infected tissues
to provide protection during infection.
To probe the role of MAIT cells in infection in vivo, antibacte-
rial immune responses have been compared in MR1-deficient
(MR1/) and wild-type (WT)mice; however, findings using this
approach thus far have been ambiguous, complicating mechanis-
tic interpretations. For example, Le Bourhis et al. reported that
there was no significant difference in bacterial burden between
MR1/ and WT mice infected with Mycobacterium abscessus
(50). This finding was discordant with their observation that M.
abscessus activated MAIT cells in vitro. In a subsequent study,
Georgel et al. reported that MR1 was not required for bacterial
clearance after infection with E. coli, Shigella dysenteriae, or Yer-
sinia enterocolitica, but MAIT cells were required for clearance of
Klebsiella pneumoniae (32). It is unclear why in vitro activation
experiments showed that mouse MAIT cells respond to APCs in-
fectedwith diversemicrobes, yetmost in vivo experiments showed
thatMR1/micewhich lackMAIT cells are not impaired in their
ability to control infection with most bacterial strains tested. A
possible explanation of this conundrum is that WT mice lack a
sufficient number of MAIT cells to show an antibacterial pheno-
type. Consistent with this explanation, V19-J33 TCR-trans-
genic mice that overexpress MAIT cells had lower bacterial loads
than control mice after infection with E. coli orM. abscessus (50).
However, because theTCR-transgenicmice used in these compar-
isons have few if any conventional CD4 and CD8 T cells, this
model system lacks physiologic context or the ability to address
the question of whether MAIT cells have a nonredundant role in
controlling bacterial infection (12). Another possible explanation
to the inconsistency between in vivo and in vitro studies is that
perhaps an infection model in mucosal tissues, where MAIT cells
mainly reside, needs to be employed. To our knowledge, in vivo
infections that have been reported so far to compareMR1/ and
WT mice are conducted through intraperitoneal injection (32,
50). The in vivo role of MAIT cells may be overlooked in the
systemic challenge and therefore did not provide results that cor-
related with the in vitro reactivity to diverse microbes.
To determine whether MAIT cells function as innate T cells
and what unique role they might play in bacterial infection, we
employed in vitro and in vivo assays and identified a robust phe-
notype. Using theMycobacterium bovis bacillus Calmette-Guerin
(BCG) infection in vitro, we showed that MAIT cells secrete
gamma interferon (IFN-), which enhances the antibacterial ac-
tivity of infected M in a manner dependent upon IL-12/23p40.
Unexpectedly, the antibacterial activity in these in vitro assays was
found to be largely independent of MR1 expression by infected
M, even though MR1 expression is required during ontogeny
for MAIT cells to acquire their innate function. Furthermore, our
in vivo studies using low-dose aerosol challenge showed that
MR1/ mice had significantly higher bacterial loads in the lung
after mycobacterial infection thanWTmice. These findings dem-
onstrate that the antibacterial activity of MAIT cells is unique and
not redundant with the activities of other innate T-cell popula-
tions in the immune system.
MATERIALS AND METHODS
Mice.C57BL/6 and IL-12/23p40/mice were purchased fromThe Jack-
son Laboratory. MR1/, V19iTgMR1/, and V19iTgMR1/mice
(all C57BL/6 background) were gifts from S. Gilfillan (Washington Uni-
versity). The V19i transgene in these mice is the canonical TCR V of
Antibacterial Function of MAIT Cells
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MAIT cells shared by90%ofmouseMAIT cells, andMAIT cells isolated
from the transgenicmice used in this study have limited endogenous TCR
V usage and surface marker characteristics of polyclonal MAIT cells
(45). Mice were bred and maintained under specific-pathogen-free con-
ditions and were used by protocols in the studies approved by the Animal
Studies Committee of Washington University.
Antibodies and cytokine. Anti-MR1 MAbs 26.5 and 8F2.F9 were re-
ported previously (13, 39) and used as a mixture in the in vitro cultures.
Anti-IFN- (H22) was a gift from R. Schreiber (Washington University).
Anti-IL-12/23p40MAb (C17.8) was purchased fromR&D Systems (Min-
neapolis,MN). Anti-IL17A (18H10)was purchased fromMabtech (Mari-
emont, OH). All antibodies were used at the concentration of 10g/ml in
the in vitro cultures. Recombinant mouse IL-12 was purchased from Pe-
protech (Rocky Hill, NJ) and reconstituted according to the instructions.
T-cell isolation. Spleen cells fromnaïvemicewere aseptically removed
and used as the source for T-cell isolation. A single-cell suspension was
prepared, and red blood cells were lysed with ammonium chloride. Cells
were washed, counted, and subjected to magnetic labeling and separation
according to the instructions of the pan-T-cell isolation kit II (130-095-
130; Miltenyi Biotec, Auburn, CA). The enriched T cells were used in the
in vitro cultures.
In vitro analysis of the inhibition of intracellular M. bovis BCG
growth in M by T cells. The procedures for analyzing the inhibition of
intracellularM. bovis BCG growth inM by T cells, including the in vitro
culture of bone marrow-derived M, the infection of mycobacteria, the
coculture of M and T cells, and the measurement of intracellular bacte-
rial growth, were adopted and modified from published reports and pro-
tocols (18, 26, 61, 77). In brief, bone marrow was flushed from femurs of
mice with D10 medium, which is Dulbecco’s modified Eagle medium
(DMEM) (Gibco, Grand Island, NY) supplemented with 10% heat-inac-
tivated fetal calf serum (HyClone, Logan, UT), 2 mM L-glutamine (Me-
diatech, Manassas, VA), 10 mM HEPES buffer (Mediatech, Manassas,
VA), 1	 nonessential amino acids (Mediatech, Manassas, VA), 1 mM
sodium pyruvate (Mediatech, Manassas, VA), 100 U/ml penicillin, and
100 g/ml streptomycin. Red blood cells were lysed, and the remaining
bone marrow cells were washed and plated at 2	 104 viable cells per well
in 96-well plates (flat bottom) in D10 medium supplemented with 20
ng/ml recombinant murine macrophage colony-stimulating factor
(rmM-CSF; 315-02; Peprotech, Rocky Hill, NJ). Cells were incubated at
37°C in 5% CO2. After 3 days, the attached cells were gently washed with
warm antibiotic-freeD10medium (D10mediumwithout penicillin and
streptomycin). The attached cells were cultured in D10 medium con-
taining fresh rmM-CSF (20 ng/ml) for an additional 4 days at 37°C in 5%
CO2. After the 7-day culture period, bone marrow-derived M formed a
confluent monolayer, and the density of M was estimated to be 2	 105
cells per well in 96-well plates. M were infected with M. bovis BCG
(Danish strain) at a multiplicity of infection (MOI) of 3:1 (bacteria to
M) in D10 medium at 37°C in 5% CO2. After overnight culture, in-
fected M were washed with D10 medium to remove the extracellular
M. bovis BCG before coculture with purified T cells. Purified T cells were
obtained as described above and added to the wells of infected M at the
ratio of 1:1 in D10 medium at 37°C in 5% CO2 for 72 h. At the end of
coculture, supernatants were collected for the measurement of the pro-
duction of cytokines and nitric oxide. Cells were lysed with 0.2% saponin
to release intracellular M. bovis BCG. Mycobacteria were radiolabeled
with tritiated uridine as previously described (77) to determine the viabil-
ity of bacteria under different coculture conditions. Briefly, [5,6-3H]uri-
dine (Perkin Elmer,Waltham,MA) at 1Ci/ml prepared inMiddlebrook
7H9 broth supplemented with 10% ADC enrichment medium (BD BBL
211887; Becton, Dickinson, Franklin Lakes, NJ) was added to saponin
lysates. After incubation at 37°C for 72 h, the tritiated uridine-pulsed
mycobacteria were harvested (Tomtec Harvester 96 MACH III M;
Tomtec, Hamden, CT) onto glass fiber filters (Perkin Elmer, Waltham,
MA), and radioactivity was quantitated by liquid scintillation counting
(Wallac MicroBeta TriLux 1450; Perkin Elmer, Waltham, MA). The per-
centages of M. bovis BCG growth inhibition under different coculture
conditionswere calculated by the following formula: percent inhibition

100 [100	 (disintegrations perminute fromT cell-infectedM cocul-
tured wells/disintegrations per minute from infected M alone wells)].
Measurement of cytokine and nitric oxide (NO) production. Cul-
ture supernatants were collected after 72 h of coculture. The concentra-
tion of IFN- and IL-17A was quantified by standard sandwich ELISAs
according to themanufacturer’s instruction (R&D Systems,Minneapolis,
MN). NO production was measured by the Griess reaction, using com-
mercial Griess reagent (G4410; Sigma-Aldrich, St. Louis, MO). Serially
dilutedNaNO2 (S-2252; Sigma-Aldrich, St. Louis) (0 to 100M)was used
to generate a standard curve to quantify the amount of nitrite (NO2
) in
supernatants (37, 57, 62).
In vivo infection of M. bovis BCG. WT and MR1/ mice were in-
fected with M. bovis BCG (Danish strain) via aerosol or the intranasal
route. In the aerosol infection,M. bovisBCGwas diluted to 107 CFU/ml in
phosphate-buffered saline (PBS) with 0.04% Tween 80. A nebulizer (bio-
aerosol nebulizing generator [BANG]; CHTechnologies) was set to liquid
feed at 1ml/min and airflow at 1 liter/min to exposemice toM. bovisBCG.
A 20-min exposure to the aerosol resulted in the delivery of 100 to 300
infectious bacilli per mouse lung. In the intranasal infection, WT and
MR1/mice were injectedwithM. bovisBCG via the nares (107 CFUper
mouse) while mice were under anesthesia and laid on their dorsal side on
a plastic mouse holder (60). On day 10 and 30 postinfection, the lungs
were harvested and homogenized. To determine the mycobacterial colo-
nization, the lung homogenate was serially diluted (1:10 and 1:100) and
plated onMiddlebrook 7H10 agar plates supplemented with 10%OADC
(oleic acid-albumin-dextrose-catalase) enrichment medium (BD BBL
212240; Becton, Dickinson, Franklin Lakes, NJ). Two to three weeks later,
mycobacterial CFU had formed on the agar plates and were counted.
Ex vivo stimulation of bronchoalveolar lavage (BAL) cells by myco-
bacterial antigens and IFN- enzyme-linked immunosorbent spot
(ELISPOT) analysis.Todetermine the IFN- response elicited in the lung
byM. bovis BCG infection, bronchoalveolar lavage (BAL) cells from WT
andMR1/micewere harvested. BAL cells from the same genotypewere
pooled and used in the ELISPOT assay. The BAL cells were stimulated ex
vivo with M. bovis BCG (MOI 
 3) or various antigens derived from M.
tuberculosis, including culture filtrate proteins (CF) (10 g/ml; Colorado
State University, Fort Collins, CO), cell wall (CW) fraction (50 g/ml;
Colorado State University, Fort Collins, CO), and the Ag85B peptide pool
(Ag85Bpp) (2 g/ml; JPT Peptide Technologies GmbH, Berlin, Ger-
many). The frequency of IFN--producing cells in the BAL cells wasmea-
sured by ELISPOT analysis. Anti-IFN-MAbs, clones AN18 and R4-6A2
(biotinylated), were purchased from eBioscience (San Diego, CA) and
used as a pair to capture the release of IFN- of BAL cells. Streptavidin-
alkaline phosphatase (ALP) (Mabtech, Mariemont, OH) and BCIP/NBT
(5-bromo-4-chloro-3-indolylphosphate–nitroblue tetrazolium) sub-
strate (Fisher Scientific, Pittsburgh, PA) were used to visualize the IFN-
spot-forming units (SFUs). A CTL-ImmunoSpot S6 microanalyzer and
ImmunoSpot professional software (Shaker Heights, OH) were used to
quantitate the SFUs.
RESULTS
MR1-restricted MAIT cells have an innate function and inhibit
mycobacterial growth in M. To define the potential role of
MAIT cells in controlling bacterial infection, we established an in
vitro infection assay whereby purifiedMAIT cells were cocultured
with M. bovis BCG-infected M. In these coculture assays, puri-
fied transgenic MAIT cells composed of 50% of DN, 25% CD8,
and 25% CD4 T cells (45) (data not shown) from naïve
V19iTgMR1/mice were used. As a negative control, purified
naïve T cells from V19iTgMR1/ mice were included (45). In
thesemice, T cells that express theV19-J33 transgene are found
in the periphery, but due to the lack of selection by MR1 during
Chua et al.
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development, these T cells do not display MAIT cell characteris-
tics, including cytokine secretion, effector/memory phenotype,
and bias in the TCR usage (45, 55). For comparisons, we also
included naïve T cells from WT mice that have a very low fre-
quency ofMAIT cells and fromMR1/mice that lack detectable
MAIT cells (72). These various populations of naïve T cells were
cocultured with M. bovis BCG-infected M. As shown in Fig. 1a
and b, MAIT cells inhibited the intracellular growth of M. bovis
BCG in M by 40 to 80% (varying in several independent exper-
iments) compared to bacterial growth in M in the absence of
MAIT cells. Importantly, control transgenic T cells from
V19iTgMR1/mice showed no inhibition of bacterial growth
inM. bovis BCG-infected M (Fig. 1a and b). Thus, the antibac-
terial function of V19-J33 TCR-bearing T cells requires MR1
selection during development. T cells from naïve MR1/ and
WTmice also failed to inhibit the intracellular growth ofM. bovis
BCG in M, suggesting that normal levels of MAIT cells or other
innate T cells are not sufficient to control the mycobacterial
growth in these coculture assays (Fig. 1a and b). In addition,
MAIT cells, but not control transgenic T cells, enhanced nitric
oxide (NO) production by infected M (Fig. 1c), indicating an
increase in microbicidal activity of M and providing further ev-
idence of the ability of MAIT cells to control bacterial infection.
MAIT cells are a potent source of innate IFN-. IFN- is a key
cytokine for optimal antimycobacterial immunity (16, 28, 29). In
the early stage of infection, innate T cells andNKcells are activated
by mycobacterium-infected M to release IFN- (27, 49, 66).
This innate source of IFN- is indispensable for enhancement in
bactericidal activity of M, including the induction of inducible
nitric oxide synthase (iNOS) (54). It has been shown that human
MAIT cells produce IFN- in response to mycobacterium-in-
fected APCs (33, 50). However, whether IFN- production is re-
quired for MAIT cells to control mycobacterial growth was not
previously investigated. To address this question, we first deter-
mined whether mouseMAIT cells secrete IFN-when cocultured
withM. bovis BCG-infected M. As shown in Fig. 2a, MAIT cells
responding to infected M had high levels of IFN- produc-
tion. In contrast, the supernatant from the cocultures of
V19iTgMR1/, WT, or MR1/ T cells showed low, if any,
IFN- production (Fig. 2a). To test whether IFN- production by
MAIT cells was required for the control of mycobacterial growth,
anti-IFN- blocking antibody was added to the coculture. Anti-
IFN- antibody ablated the inhibition of bacterial growth by
MAIT cells (Fig. 2b) and also suppressed the enhancement of NO
production by MAIT cells (Fig. 2c). These findings suggested that
MAIT cells are a potent source of innate IFN- which is required
for their ability to control mycobacterial growth in M.
Activated MAIT cells produce IL-17A in response to infec-
tion. In addition to IFN-, MAIT cells have also been reported to
produce IL-17 in response to mitogenic or cytokine stimulations
(10, 25). These finding raise the question of whether MAIT cells
secrete IL-17 when encountering bacterium-infected APCs. As
shown in Fig. 3a, MAIT cells produced high levels of IL-17A when
cocultured withM. bovis BCG-infected, but not uninfected, M.
To determine whether IL-17A secretion was required for MAIT
cell control of the intracellular growth, an anti-IL-17A blocking
antibodywas added to the coculture. Interestingly, the blockage of
IL-17 in the coculture did not affect the ability of MAIT cells to
control the intracellular growth ofM. bovis BCG inM (Fig. 3b).
The combined results (Fig. 2 and 3) suggest that during infection,
MAIT cells produce IFN- to provide direct control of bacterial
growth in infected APCs, whereas their IL-17 production may
help stimulate the adaptive immune response (see below).
Effector function of MAIT cells is dependent on the innate
signal IL-12 from infected M. Next, we sought to dissect the
mechanism by which APCs activate MAIT cells during infection.
iNKT cells can receive two signals from APCs during infection (8,
74). One signal is the cognate interaction between CD1d/lipid
complexes on APCs and TCRs on iNKT cells (6), whereas the
more dominant signal was recently shown to be IL-12 secretion by
the microbe-infected APCs (9). Our results have demonstrated
thatMR1 is required forMAIT cells during development to obtain
their effector function (Fig. 1 and 2a; also, see Fig. S1 in the sup-
plemental material). To determine if cognate recognition of MR1
FIG 1 Innate MR1-restricted MAIT cells inhibit mycobacterial growth in
M. (a and b) M. bovis BCG-infected M derived from WT mice were cul-
tured alone or cocultured with naïve T cells from MR1/, WT,
V19iTgMR1/, or V19iTgMR1/mice for 72 h. The intracellular growth
of mycobacteria in M was quantitated by liquid scintillation counting of
tritiated uridine uptake (disintegrations perminute) (a). (b) The percentage of
mycobacterial growth inhibition was assessed from radioactivity in panel a to
demonstrate the extent of suppression ofmycobacterial growth by naïve T cells
from different mice. See Materials and Methods for the formula used in
the calculation of the percentage. (c) Nitric oxide (NO) production by unin-
fected M, infected M, or infected M cocultured with naïve T cells
(V19iTgMR1/ or V19iTgMR1/). Supernatants were collected after 72
h of culture. The amount of nitrite (NO2
) in supernatants was measured.
Results are means  standard errors of the means (SEM) of the triplicate of
different culture conditions. Statistical analysis was performed using a one-
way analysis of variance (ANOVA)with Tukey’s multiple comparison posttest
comparing every culture condition (***, P  0.001; ns, not significant). The
dotted line in panel c indicates that the uninfected M were not included in
statistical comparison. Data are results from one of three independent exper-
iments.
Antibacterial Function of MAIT Cells
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on infected M is required for MAIT cell activation, anti-MR1
blocking MAbs (13, 33, 39, 50) or MR1/M were used in the
coculture assay. Surprisingly, anti-MR1 MAbs did not block
MAIT cell production of IFN- and IL-17A (Fig. 4a and c) or
enhancement of NO production (Fig. 4e) when cocultured with
WTM infected withM. bovis BCG. Furthermore, MR1/M
infected with M. bovis BCG elicited MAIT cell responses compa-
rable to those obtained with infected WT M (Fig. 4b, d, and f).
Thus, the cognate recognition of MR1 on infected cells was not
required for MAIT cytokine responses to infected APCs.
To determinewhether the IL-12 signal from infected APCswas
responsible for MAIT cell activation, we took advantage of anti-
IL-12/23p40 blocking MAb and M from mice deficient in the
IL-12/23p40 gene (p40/). The coculture experiments showed
that WTM infected withM. bovis BCG failed to activate MAIT
cells in the presence of anti-IL-12/23p40 MAb (Fig. 4a, c, and e).
Furthermore, p40/ M infected with M. bovis BCG did not
elicit IFN- or IL-17A production (Fig. 4b and d) or support en-
hancement of NO production by MAIT cells (Fig. 4f).
We next tested whether MR1-recognition and IL-12 secretion
were required for the ability of MAIT cells to control the intracel-
lular bacterial growth in infected M. As shown in Fig. 5a and c,
anti-IL-12/23p40 MAb blocked the anti-bacterial activity of
MAIT cells, but anti-MR1 MAbs did not (Fig. 5a and c). Further-
more, MAIT cells were not able to control bacterial growth in
p40/M but were still effective in inhibiting bacterial growth
FIG 2 MAIT cells are a potent source of innate IFN- enhancing the micro-
bicidal activity of infected M. (a) IFN- production by naïve T cells from
MR1/, WT, V19iTgMR1/, and V19iTgMR1/ mice when cocul-
tured with uninfected or M. bovis BCG-infected M. Supernatants were col-
lected after 72 h of coculture. The concentration of IFN- in supernatants was
measured by ELISA. (b) Effect of IFN- blockage on the inhibition of myco-
bacterial growth by V19iTgMR1/ T cells.M. bovis-infected M were cul-
tured alone or cocultured with V19iTgMR1/ T cells in the absence or
presence of an anti-IFN- MAb for 72 h. The intracellular growth of myco-
bacteria in M was quantitated by liquid scintillation counting of tritiated
uridine uptake (disintegrations per minute). (c) Effect of IFN- blockage on
the enhancement in NO production of infected M by V19iTgMR1/ T
cells. Supernatants from the cultures used for panel b were collected before cell
lysis for the radiolabeling of mycobacteria. The amount of NO2
 in superna-
tants was measured. Results are the means  SEM from triplicate assays of
each set of culture conditions. Statistical analysis was performed using a one-
wayANOVAwith Tukey’smultiple comparison posttest comparing all culture
conditions (*, P 0.05; **, P 0.01; ***, P 0.001; ns, not significant). Data
are results from one of three independent experiments.
FIG 3 Innate MAIT cells produce IL-17A in response to infection. (a) IL-17A
production of V19iTgMR1/ T cells when cocultured with uninfected or
M. bovis BCG-infected M. Supernatants were collected after 72 h of cocul-
ture. The concentration of IL-17A in supernatants wasmeasured by ELISA. (b)
Effect of IL-17A blockage on the inhibition of mycobacterial growth by
V19iTgMR1/ T cells. M. bovis BCG-infected M were cultured alone or
cocultured with V19iTgMR1/ T cells in the absence or presence of an
anti-IL-17A MAb for 72 h. The intracellular growth of mycobacteria in M
was quantitated by liquid scintillation counting of tritiated uridine uptake
(disintegrations per minute). Results are means SEM from triplicate assays
of each set of culture conditions. Statistical analysis was performed using a
one-way ANOVA with Tukey’s multiple comparison posttest comparing all
cultures (***, P 0.001; ns, not significant). Data are results from one of three
independent experiments.
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in MR1/ M (Fig. 5b and d). The MAIT cell dependence on
IL-12 was also revealed by the addition of anti-IL-12/23p40 MAb
to the coculture with MR1/ M infected with M. bovis BCG,
where MAIT cell activation and effector function were blocked
(data not shown). Thus, these in vitro findings highlight the im-
FIG 4 Activation of MAIT cells is dependent on the innate signal IL-12 from
infectedM. (a, c, and e)MAIT cell activation in the presence of anti-MR1 or
anti-IL-12/23p40 MAbs. V19iTgMR1/ T cells were cocultured with M.
bovis BCG-infected M, and supernatants were collected after 72 h of cocul-
ture. The concentrations of IFN- (a), IL-17A (c), and NO2
 (e) in superna-
tants were measured. Results are means SEM from triplicate assays of each
set of culture conditions. Statistical analysis was performed using a one-way
ANOVA with Tukey’s multiple comparison posttest comparing all cultures.
***, P  0.001; ns, not significant (for comparisons to results obtained with
M cocultured with V19iTgMR1/ T cells in the absence of blocking
MAbs). The dotted line in panel e indicates that the NO production by M
cultured alone was not included in the statistical comparison. Data are the
results from one of three independent experiments. (b, d, and f) Activation of
MAIT cells cocultured with WT, MR1/, or p40/ M infected with M.
bovis BCG. V19iTgMR1/ T cells were cocultured with WT, MR1/, or
p40/M infected withM. bovis BCG and supernatants, were collected after
72 h of coculture. The concentration of IFN- (b), IL-17A (d), andNO2
 (f) in
supernatants were measured. Results are means SEM from triplicate assays
of each set of culture conditions. Statistical analysis was performed using a
one-way ANOVA with Tukey’s multiple comparison posttest comparing all
cultures. ***, P  0.001; ns, not significant (for comparisons to results ob-
tained withWTM cocultured with V19iTgMR1/ T cells). In panel f, the
dotted line indicates that statistical analyses were performed separately forM
alone and M cocultured with V19iTgMR1/ T cells. There was no statis-
tical difference in NO production among infected M of different genotypes
cultured in the absence of V19iTgMR1/ T cells. Data are results from one
of two independent experiments.
FIG 5 Control of mycobacterial growth by MAIT cells depends on IL-12. (a
and c) The inhibition ofmycobacterial growth byMAIT cells in the presence of
anti-MR1 or anti-IL-12/23p40 MAbs. M. bovis-infected M were cultured
alone, or cocultured with V19iTgMR1/ T cells in the absence or presence
of anti-MR1 MAbs or an anti-IL-12/23p40 MAb for 72 h. The intracellular
growth of mycobacteria in M was quantitated by liquid scintillation count-
ing of tritiated uridine uptake (disintegrations perminute) (a). The percentage
ofmycobacterial growth inhibition (c)was assessed from radioactivity in panel
a to demonstrate the extent of suppression of mycobacterial growth by
V19iTgMR1/ T cells in the absence or presence of blocking MAbs. See
Materials andMethods for the formula used to calculate inhibition. Results are
means SEM from triplicate assays of each set of culture conditions. Statisti-
cal analysis was performed using a one-way ANOVA with Tukey’s multiple
comparison posttest comparing all cultures. **, P  0.01; ns, not significant
(for comparison to results obtained with M cocultured with
V19iTgMR1/ T cells in the absence of blocking MAbs). The dotted line in
panel a indicates that M cultured alone were not included in statistical com-
parison.Data are results fromone of three independent experiments. (b and d)
Inhibition of mycobacterial growth inWT,MR1/, or p40/M byMAIT
cells. WT, MR1/, or p40/M infected withM. bovis BCG were cultured
alone or cocultured with V19iTgMR1/ T cells for 72 h. The intracellular
growth of mycobacteria in M was quantitated by liquid scintillation count-
ing of tritiated uridine uptake (disintegrations perminute) (b). The percentage
of mycobacterial growth inhibition (d) was assessed based on genotype. Re-
sults are means SEM of the triplicate of different culture conditions. Statis-
tical analysis was performed using a one-way ANOVA with Tukey’s multiple
comparison posttest comparing all cultures. ***, P 0.001; ns, not significant
(for comparison to results obtained with the coculture of infected WT M
with V19iTgMR1/ T cells). In panel b, the dotted line indicates that statis-
tical analyses were performed separately for M alone and M cocultured
with V19iTgMR1/ T cells. There was no statistical difference in mycobac-
terial growth among infected M of different genotypes cultured in the ab-
sence of V19iTgMR1/ T cells. Data are results from one of two indepen-
dent experiments.
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portance of MAIT cell control of intracellular bacterial growth in
M by a mechanism that is IL-12 dependent and show that in the
presence of an innate IL-12 signal, the requirement for cognate
engagement of MR1 by MAIT cells was not detected.
The above observations indicated that the IL-12 signal rather
than MR1 recognition may dominate MAIT cell activation and
effector function in bacterial infection. However, it remained pos-
sible that an MR1-restricted interaction between MAIT cells and
Mmay be masked by a strong IL-12 signal. To test this possibil-
ity, we added anti-MR1 MAbs to the coculture of MAIT cells and
p40/M infected withM. bovis BCG. As shown in Fig. 6a and
b, anti-MR1 MAbs further decreased the already defective pro-
duction of IFN- and IL-17A by MAIT cells in the absence of
IL-12 signal from infected M. However, the decrease in MAIT
cell cytokine production by anti-MR1 MAbs was not reflected in
the control ofM. bovis BCGgrowth in p40/M (Fig. 6c). These
data suggested that the MR1/TCR-mediated signal may be weak
and/or transient. IL-12was shown to amplifyweakTCR-mediated
activation of iNKT cells (9). The addition of recombinant IL-12
stimulated MAIT cells cocultured with uninfected WT M to
release IFN- in a dose-dependent manner (Fig. 7). In compari-
son, control T cells from V19iTgMR1/mice did not respond
to recombinant IL-12. We concluded from these mechanistic
studies that the innate signal IL-12 is indispensable for MAIT cell
function of controlling bacterial infection. In contrast, certain ef-
fector functions of MAIT cells may be MR1 independent, in spite
of the critical role of MR1 expression during development.
MR1-restricted MAIT cells play a unique role in protective
immunity against mycobacterial infection in vivo. From our in
vitro observations, MAIT cells appear to function as innate lym-
phocytes and are capable of controlling mycobacterial infection.
To test the hypothesis thatMAIT cells play a nonredundant role in
providing immunity against infection, we infected MR1/mice
with a low dose of M. bovis BCG via the aerosol route. At day 10
postinfection,MR1/mice showed significantly higher bacterial
burdens in the lung than WT mice (Fig. 8a). However, MR1/
and WTmice showed similar bacterial loads in the lung at day 30
postinfection (Fig. 8a). These results suggest that MAIT cells con-
tribute to controlling bacterial growth at the early stage of infec-
tion. To detect a greater cytokine response, we increased the in-
fection dose and deliveredM. bovis BCG via the intranasal route.
Consistent with the result in the aerosol challenge, MR1/mice
had higher bacterial burden in the lung than WT mice at day 10
after intranasal infection (data not shown). Furthermore, when
stimulated ex vivowithM. bovisBCG and various antigens derived
fromM. tuberculosis, bronchoalveolar lavage (BAL) cells from in-
fected MR1/ mice showed a lower IFN- response than BAL
cells fromWTmice (Fig. 8b). The antigens tested included culture
filtrate proteins (CF) and cell wall (CW) fractions fromM. tuber-
culosis H37Rv. Of note, a previous study suggested that the CW
fraction of M. tuberculosis stimulated CD8 human MAIT cell
clones (33). Thus, the lower IFN- response of MR1/ BAL cells
after infection may result from the lack of MAIT cells responding
to mycobacterial antigens ex vivo. However, it is difficult to inter-
pret these findings without definitive evidence that MR1 binds a
ligand and, if so, whether it is microbe derived or an infection-
induced self-ligand. Alternatively, BAL cells from infected
MR1/ mice also showed a lower IFN- response to Ag85Bpp,
the peptide pool of known immunodominant epitopes of Ag85B
recognized by CD4 and CD8 T cells (1, 44, 53), suggesting a
poorer adaptive immune response in MR1/ mice during M.
bovisBCG infection. Because IL-17A is known to be important for
driving TH1 immunity in the lung after the infections of intracel-
lular pathogens (36, 46, 47, 51), we speculated that the defective
IL-17 response in MR1/ mice due to the lack of MAIT cells
results in failure to recruit CD4 and CD8 T cells to the site of
infection. In fact, BAL cells from infectedMR1/mice produced
FIG 6 The role ofMR1 inMAIT cell activation. (a and b)MAIT cell activation
by p40/ M in the presence of anti-MR1 MAbs. V19iTgMR1/ T cells
were coculturedwith p40/M infectedwithM. bovisBCG in the absence or
presence of anti-MR1 MAbs. Supernatants were collected after 24 or 72 h of
coculture. (c) The inhibition of mycobacterial growth in p40/ M by
V19iTgMR1/ T cells in the absence or presence of anti-MR1 MAbs. Re-
sults are means SEM from triplicate assays of each set of culture conditions.
Statistical analysis was performed using Student’s t test. Although there was a
trend for cytokine secretion of V19iTgMR1/ T cells to be lower in the
presence of MR1 blockage, the difference was not statistically significant. Data
are results from two time points in two independent experiments.
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less IL-17A than infectedWTmice in response to the CW fraction
of M. tuberculosis (Fig. 8c). The functional relevance of the pub-
lished reports thatMAIT cells accumulated at the site of infections
(33, 50) is supported by the evidence reported here that MAIT
cells are a potentially significant source of IFN- and IL-17A. In
any case, the overall implication of these findings is that MAIT
cells not only play a unique role among innate lymphocytes but
may also predispose adaptive lymphocytes to mount protective
immune responses during infection.
DISCUSSION
In this study, we provide in vitro and in vivo evidence that MAIT
cells exert unique innate functions to control mycobacterial
growth. In a coculture assay of purifiedMAIT cells and mycobac-
terium-infected M, MAIT cells were found to curtail growth of
intracellular bacterial replication associated with the secretion of
IFN- and IL-17A, known mediators of immunity against intra-
cellular and extracellular bacterial infection (17, 19, 22, 42, 47, 63,
80). Furthermore, the “first-line” production of IFN- and IL-
17A by innate lymphocytes is known to play an important role in
bridging innate and adaptive immunity (3, 21, 36, 46, 51, 67).
Although both IFN- and IL-17A of MAIT cells were induced
during the coculture with mycobacterium-infected M, the con-
trol of mycobacterial growth was dependent only upon IFN-.
Thus, IL-17A secretion by MAIT cells likely has a role other than
the direct impact on bacterial intracellular growth in the myco-
bacterial infection model used here.
Importantly, the antibacterial activity of MAIT cells in our in
vitro assays was found to be critically dependent upon their in vivo
development in MR1-positive mice. Although inWTmice MAIT
cell development is MR1 dependent, in transgenic mice express-
ing the MAIT cell canonical V19-J33 TCR chain, V19i T
cells can develop in both Mr1/ and Mr1/ mice. However,
only MR1-educated V19i T cells have a MR1-dependent bias in
TCR chain usage and exhibit effector/memory and cytokine se-
cretion profiles like nontransgenic MAIT cells (45, 55). In com-
plete agreement with this conclusion from previous studies, only
V19i transgenic T cells developing in the MR1-positive mice
were found to control intracellular bacterial growth in our in vitro
assays. Surprisingly, however, theseMAIT cells selected byMR1 in
vivo were found not to rely on MR1 engagement to impair intra-
cellular bacterial replication in vitro. Indeed, this conclusion was
supported by both the failure of anti-MR1 MAbs to block the
antibacterial activity ofMAIT cells and the observation thatMAIT
cells controlled bacterial growth inMR1/M. Thus, theMAIT
cell effector function in vitro did not require TCR recognition of
MR1 on infected APCs. In contrast, our observations suggest a
noncognate pathway of MAIT cell activation mediated by the in-
nate signal IL-12 during mycobacterial infection. Abolishing the
IL-12 signal from infected APCs (with the use of anti-IL-12/23p40
MAb or p40/ M) diminished the effector function of MAIT
cells, including IFN- and IL-17A production as well as the inhi-
bition of mycobacterial growth. Of note, when the IL-12 signal
was prevented, anti-MR1MAbs partially inhibited the anti-bacte-
rial activity of MAIT cells, suggesting that an MR1-dependent
component may be masked by a strong innate IL-12 signal.
Interestingly, besides infection,MAIT cells have been reported
to play a regulatory role in mouse models of autoimmunity (10,
20, 58, 68). For example, Croxford et al. showed that MAIT cells
provide protection in murine autoimmune encephalomyelitis
(EAE) by inducing the IL-10 production by B cells (20). However,
this protectivemechanismwas shown to beMR1 independent and
partly ICOS dependent. More recently, Chiba et al. showed that
MAIT cells adoptively transferred into MR1/ mice augment
collagen antibody-induced arthritis (10). To explain how MAIT
cells modulate the immune response in the absence of MR1, their
in vitro analyses showed that MAIT cells are stimulated to prolif-
erate by IL-1 and to produce IL-17A by IL-23 in the absence of
TCR signals (10). In the present study, MAIT cells were found to
release IFN- by the stimulation of IL-12 in the absence of infec-
tion. In accordance with these examples of cytokine driven acti-
vation, human MAIT cells express high levels of IL-12R2 and
IL-23R (2, 5). These combined findings point toward a model in
which, after selection by MR1 in thymus, MAIT cells are pro-
grammed to respond to innate signals, at least some of which can
occur without concurrent MR1 recognition. Alternatively, after
egress from the thymus, MAIT cells adapt by quickly responding
to infection (34). During infection,MR1 on either APCs orMAIT
cells themselves may be a sufficient signature to allow MAIT cell
activation by an innate cytokine signal.
Despite the above evidence of the non-MR1-dependent func-
tions of MAIT cells, previously published studies have provided
evidence for cognate interaction between MR1 and MAIT cells
using the anti-MR1MAbs used in this study (13, 33, 39–41, 50). In
earlier mouse studies, MAIT cell hybridomas were selected based
on TCR usage, and a small fraction of these MAIT hybridomas
were found to be activated by MR1-overexpressing cell lines in a
manner blockable by MAbs to MR1 or TCR (13, 39, 56). More
recently, mouse MAIT cells from V19 TCR-transgenic mice as
well as serologically isolated polyclonal human MAIT cells were
found to express activation markers after culture with bacterium-
infected cells in a manner that was also blockable with anti-MR1
MAb (50). In addition, numerous CD8 humanMAIT cell clones
with activity against cells infected with M. tuberculosis and other
bacteria were found to be blocked by anti-MR1 MAb (33). Al-
though the above-mentioned studies provide compelling evi-
dence for the occurrence of the MR1-dependent activation of
MAIT cells, its overall importance relative to noncognate activa-
FIG 7 MR1-restrictedMAIT cells produce IFN- in response to recombinant
IL-12 in the absence of infection. V19iTgMR1/ or V19iTgMR1/ T
cells were incubated with uninfected WTM in the presence of recombinant
IL-12 at various concentrations. Supernatants were collected after 24 h of
incubation. The concentration of IFN- in supernatants was measured by
ELISA. Results are means  SEM from triplicate assays of each set of culture
conditions. Statistical analysis was performed using a two-way ANOVA
(***, P 0.001). Data are results from one of two independent experiments.
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tion is difficult to assess without a better definition of functional
heterogeneity within polyclonal MAIT cells.
As a notable parallel, the studies of iNKT cells provide a prec-
edent for how innate T cells bearing limited TCR repertoires em-
ploy multiple mechanisms to control microbial infections (6, 8,
74). More specifically, iNKT cells react to microbial infections
through at least three activation pathways: microbial antigen-
driven, cytokine- and self-antigen-driven, and cytokine-driven
pathways (8, 74). While microbial and self lipid antigens detected
by iNKT cells have been identified (7, 8, 48, 74), recent studies
show that the dominant IL-12 signal fromAPCs duringmicrobial
infection occurs independently of whether microbes express
CD1d-presented antigens (9, 15). The IL-12 signal is thought to be
an essential factor that enables iNKT cells to respond to a wide
variety of microbes with limited TCR repertoires (8, 74). In the
case of self-ligand recognition, IL-12 can provide costimulation to
amplify a weak TCR-mediated signal (8, 9, 74). Moreover, during
viral infection, cytokines, including IL-12 and IL-18, dominate the
iNKT cell activation, while CD1d presentation is not required
(shown by the use of CD1d/ mice and/or anti-CD1d MAb)
FIG 8 MR1-restricted MAIT cells play a unique role in providing protective immunity against mycobacterial infection in vivo. (a) The bacterial burden in WT
andMR1/mice in the low-dose aerosol infection ofM. bovis BCG.WT andMR1/mice were infected withM. bovis BCG via the aerosol route. Eachmouse
received 100 to 300 infectious bacilli in lung. Ten and 30 days after infection, lung tissues were harvested to determine the bacterial burden. Results are given as
the mean SEM of five mice per group. Each dot represents the CFU count for one mouse. The difference in bacterial burden betweenWT andMR1/mice
at day 10 postinfection is statistically significant as analyzed by Student’s t test (P
 0.0008). Data are results fromone of two independent experiments. (b) IFN-
responses of WT andMR1/mice to intranasal infection withM. bovis BCG. BAL cells were obtained fromWT andMR1/mice on day 10 and day 30 after
intranasal infection ofM. bovis BCG (107 CFU per mouse). The frequency of IFN--producing cells in the BAL cells was measured by ELISPOT assay. BAL cells
from the same genotype were pooled and stimulated withM. bovis BCG (MOI
 3) and variousM. tuberculosis-derived antigens: culture filtrate (CF, 10g/ml),
cell wall (CW, 50g/ml), and anAg85b peptide pool (Ag85bpp, 2g/ml). The numbers of IFN- SFUs per onemillion BAL cells were assessed. Results aremeans
 SEM from triplicate assays of each set of culture conditions. Data are results from one of two independent experiments. (c) IL-17A production in the
supernatant of BAL cells stimulated by the CW fraction ofM. tuberculosis ex vivo. Results are means SEM from triplicate assays. Data are results from one of
two independent experiments.
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(75). The constitutive expression of high levels of IL-12 receptor
on iNKT cells provides an explanation for the immediate response
of iNKT cells to cytokine-driven activation (9). It is likely that,
since they sharemany innate-type features with iNKT cells, MAIT
cells are also equipped for rapid responses using cognate and non-
cognate pathways of activation.
By bridging innate and adaptive immune responses, innate-
type T cells are critical for providing the first-line protection
against infection (65). In this role, different innate lymphocyte
populations share redundant functions. For example, NK cells, 
T cells, and iNKT cells contribute to innate IFN- and/or IL-17A
production, but mice lacking functional NK cells,  T cells, or
iNKT cells are not more susceptible to mycobacterial infection
(24, 27, 31, 43, 49, 52, 69). Although MR1/ mice have normal
development of these other innate lymphocytes (72), we show
here that MR1/mice are defective in the early control of myco-
bacterial infection. The inability of MR1/ mice to elicit a pro-
tective immune response is likely due to the defective IFN- and
IL-17A production in the absence of MAIT cells. These findings
demonstrate thatMAIT cells have a nonredundant role as innate T
cells. The infection model of mycobacteria has several advantages
to define innate immune responses, including a lengthy doubling
time of mycobacteria after lung infection and a slowly developing
adaptive immune response (17).
Our in vivo findings supporting a role of MAIT cells in myco-
bacterial infection are congruent with published observations that
MAIT cells are activated in vitro by mycobacterium-infected cells
(33, 50). Similar to our findings, Georgel et al. showed that
MR1/ mice infected intraperitoneally with K. pneumoniae
failed to control bacterial burden, and serum cytokine analysis of
the infected MR1/ mice showed a decreased proinflammatory
response compared toWTmice (32). Again, congruent with these
finding, in vitro studies showed that MAIT cells displayed activa-
tion markers after coculture with cells infected with K. pneu-
moniae (50). Curiously, however, while MAIT cells also showed
strong in vitro reactivity to E. coli, another member of the family
Enterobacteriaceae (50), MR1/mice were not defective in con-
trolling E. coli infection via the intraperitoneal route (32). Simi-
larly, cells infected withM. abscessus activatedMAIT cells in vitro,
but MR1/ mice were not defective in controlling bacterial
growth in vivo (50). However, Mr1/ mice, in which all T cells
expressed the transgene of invariant TCR chain of MAIT cells,
had lower bacterial loads after infectionwith E. coli orM. abscessus
than Mr1/ mice with T cells expressing the same transgenes
(50). This finding suggested that overexpression of MAIT cells
may be required to detect their in vivo functions. However, our
report and the report by Georgel et al. (32) would suggest other-
wise. Thus, althoughMAIT cells are activated by diverse microbes
in vitro, we speculate that their in vivo roles are most prominent
when infections are introduced into mucosal tissues, when bacte-
rial replication in vivo allows a window to monitor innate effector
function, and when appropriate innate effector functions are
monitored.
Recent findings and speculations of the importance of MAIT
cells raise the question of why they were not detected sooner.
Indeed, MAIT cells were likely a factor in previously reported
findings comparing 2-microglobulin (2m)-deficient mice and
CD1d-, H2-M3-, or MHC class Ia-deficient mice (14, 23, 30, 70).
Surface expression of MR1 requires 2m assembly (56), and
2m
/ mice have been shown to be more susceptible to infec-
tions with K. pneumoniae (14) andM. tuberculosis (23) than mice
lacking Kb- and Db-restricted CD8 T cells or CD1d-restricted
iNKT cells. MAIT may also have been involved in the previous
studies of nonclassical T cells (either CD8 or CD4/CD8DNpop-
ulation) in the murine models of bacterial infection. CD8 T cells
presumably restricted by an undefined class Ib molecule repre-
sented a high percentage of IFN- producing cells in the lung of
Kb/ Db/ mice after aerosol infection with M. tuberculosis
(76). A comparative study using Kb/Db/ and Kb/Db/
M3/ showed that non-H2-M3MHCclass Ib-restrictedCD8T
cells express activated surface markers, exhibit cytotoxicity, and
produce cytokines, including IFN- and IL-17A, in response to L.
monocytogenes infection (11). Although this response was not
blocked by anti-MR1 MAb, based on our findings this could be
due to non-MR1-dependent activation of MAIT cells. Moreover,
it is possible that the role of the MAIT cells in the CD4/CD8 DN
T-cell population is overlooked in the studies focusing onCD8T
cells in Kb/ Db/ or Kb/ Db/ M3/ mice (11, 76). In
fact, a rare population of CD4 CD8 NK1.1  T cells in WT
mice was shown to inhibit the intracellular growth ofM. tubercu-
losis and Francisella tularensis (LVS) (18, 19), and these CD4/CD8
DNT cells secreted high levels of IFN- and IL-17A in response to
F. tularensis LVS infection (19). These parallels between previous
studies and recently defined features of MAIT cells support the
notion thatMAIT cells are key innate effectors against infection by
diverse microbes.
To our knowledge, this study is the first to investigate the in
vivo role of MAIT cells in a mucosal infection model. Evidence is
provided thatMAIT cells have an innate effector function andplay
a nonredundant role in the immune system during bacterial in-
fection. Mechanistically, we show that MAIT cells control bacte-
rial growth and produce proinflammatory cytokines. Further
characterization of the mechanisms by which MR1 and MAIT
cells are involved in the induction of protective immunity may
help in the future design of vaccines against bacterial infection.
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